Cas:435342-03-3 5-tert-butyl-2-(piperidin-1-ylmethyl)furan-3-carboxylic acid manufacturer & supplier

Chemical Name:5-tert-butyl-2-(piperidin-1-ylmethyl)furan-3-carboxylic acid

CAS.NO:435342-03-3

Synonyms:5-tert-Butyl-2-piperidin-1-ylmethyl-furan-3-carboxylic acid

Molecular Formula:C₁₅H₂₃NO₃

Molecular Weight:265.34800

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:367.2ºC at 760 mmHg

Density:1.115g/cm3

Index of Refraction:1.529

PSA:53.68000

Exact Mass:265.16800

LogP:3.19910

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-tert-Butyl-2-piperidin-1-ylmethyl-furan-3-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-tert-Butyl-2-piperidin-1-ylmethyl-furan-3-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-tert-Butyl-2-piperidin-1-ylmethyl-furan-3-carboxylic acid Use and application,5-tert-Butyl-2-piperidin-1-ylmethyl-furan-3-carboxylic acid technical grade,usp/ep/jp grade.

Related News: As of June’s end, there have been 100 reported GBS cases among J&J recipients, most of whom were hospitalized and one person has died, CDC officials reported. Most cases were seen in older men within 13 days following the single-dose vaccine. 3-(2,4-dimethoxy-phenyl)-5,7-dihydroxy-8-(3-methyl-but-2-enyl)-chromen-4-one manufacturers The plant will complement Recipharm’s existing sites in France, Germany and Italy and will be focused on securing approvals from regulators in Europe and the U.S. rel-(2R,6R)-2-methyl-6-(phenethylthio)tetrahydro-2H-pyran suppliers According to the Food and Drug Administration and the Orphan Drug Designation program, orphan status applies to drugs and biologics defined as “those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the US, or that affect more than 200,000 people, thallium(III) chloride monohydrate vendor & factory According to the Food and Drug Administration and the Orphan Drug Designation program, orphan status applies to drugs and biologics defined as “those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the US, or that affect more than 200,000 people, ,The plant will complement Recipharm’s existing sites in France, Germany and Italy and will be focused on securing approvals from regulators in Europe and the U.S.